Sharps Technology Inc SEC Filings

STSSW NASDAQ

Welcome to our dedicated page for Sharps Technology SEC filings (Ticker: STSSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Reading Sharps Technology’s disclosures can feel like drawing blood from a stone—hundreds of pages on syringe patents, sterilization protocols, and global manufacturing plans. Yet those details move the share price. Our platform turns that complexity into clarity.

What you’ll find here:

Sharps Technology insider trading Form 4 transactions linked to executive stock activity
Sharps Technology quarterly earnings report 10-Q filing with AI commentary on production costs
Sharps Technology Form 4 insider transactions real-time alerts—no EDGAR digging required
Sharps Technology SEC filings explained simply through AI-powered plain-language summaries
Sharps Technology earnings report filing analysis that highlights syringe demand trends
understanding Sharps Technology SEC documents with AI for faster due diligence
Sharps Technology executive stock transactions Form 4 pattern recognition tools
Sharps Technology annual report 10-K simplified—patents, plant capacity, risk factors
Sharps Technology proxy statement executive compensation unpacked line by line
Sharps Technology 8-K material events explained within minutes of posting

Our AI scans every newly posted 10-K, 10-Q, 8-K or S-1 and delivers real-time highlights: which SecureGard units shipped, how Hungarian output ramped, and whether management granted itself fresh options. Form 4 alerts surface insider moves before markets react, while keyword search points you straight to waste-reduction metrics buried deep in the footnotes. Want to compare quarter-over-quarter syringe margins? It’s pre-calculated. Need the exact wording on re-use prevention standards? One click opens the section in context.

Stop wading through technical jargon. Stock Titan’s AI-powered summaries, expert annotations, and real-time updates make Sharps Technology filings actionable, letting you focus on decisions—not document hunts.

07/03/2025 04:34 PM

Filing

[8-K] Sharps Technology Inc. Warrant Reports Material Event

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

[PRE 14A] Sharps Technology Inc. Warrant Preliminary Proxy Statement

Rhea-AI Summary

Vital Farms, Inc. (VITL) Form 4 filing dated 07/03/2025 discloses that Executive Chairperson, Director and >10% owner Matthew Ohayer sold an aggregate 30,000 shares of common stock on 07/01/2025 under a previously adopted Rule 10b5-1 trading plan (established 03/14/2025).

The sales were split into two blocks:

9,714 shares at a weighted-average price of $38.85
20,286 shares at a weighted-average price of $39.32

Based on the reported averages, total gross proceeds approximate $1.17 million (30,000 shares × ≈$39).

Post-transaction ownership stands at 6,858,890 directly held shares plus 716,000 shares held by a former spouse over which the reporting person retains voting control but no economic interest. The direct sale represents roughly 0.4% of Mr. Ohayer’s direct stake, leaving him with a sizeable position that continues to exceed the 10% beneficial-ownership threshold.

No derivative security transactions were reported, and no earnings or operational data were included in this filing.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Sharps Technology (STSSW)?

The current stock price of Sharps Technology (STSSW) is $0.0247 as of July 17, 2025.

What is Sharps Technology Inc's core business?

Sharps Technology Inc specializes in designing and manufacturing smart safety syringe products that integrate advanced safety features and ultra-low waste technology for improved drug delivery.

What safety features are incorporated in their syringe products?

Their syringes include both active and passive safety measures along with re-use prevention, ensuring protection for healthcare professionals and patients alike.

How does Sharps Technology contribute to sustainable healthcare practices?

The company employs ultra-low waste design principles in its syringe manufacturing, maximizing the efficiency of drug therapies and minimizing environmental impact.

Which markets does Sharps Technology serve?

Sharps Technology caters to a global market, providing innovative safety syringe solutions to hospitals, pharmacies, and healthcare providers across multiple regions, including Europe and the Americas.

Where are Sharps Technology's manufacturing facilities located?

The company operates a key manufacturing facility in Hungary, and it is actively pursuing partnerships to expand production capacity in the United States.

How does Sharps Technology differentiate itself from competitors?

By leveraging patented technology, the company offers syringes with unmatched safety and waste reduction features, supported by strategic manufacturing and global partnerships.

What role do strategic partnerships play in their business model?

Strategic partnerships enable Sharps Technology to expand its distribution network and meet growing market demand, enhancing its ability to supply hospitals and healthcare networks worldwide.

How do their products enhance healthcare delivery?

Their innovative syringe designs improve drug therapy efficiency, reduce the risk of needlestick injuries, and ensure a higher safety standard for both patients and medical practitioners.